Malek Chamoun
Vermogen: 47 $ op 31-05-2026
Vermogen: 47 $ op 31-05-2026
Malek Chamoun is the founder.
He founded Nora Pharma, Inc. in 2017 and currently holds the title of President.
Mr. Chamoun also worked as the Chief Development Officer at Sunshine Biopharma, Inc. Mr. Chamoun completed his undergraduate degree at Hautes Etudes Commerciales in 2008.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 18-02-2026 | 185 ( 0% ) | 47 $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
Nora Pharma, Inc.
Nora Pharma, Inc. Medical DistributorsDistribution Services Sells generic drugs | Oprichter | 01-01-2017 |
| Bedrijven | Functie | Einde |
|---|---|---|
| SUNSHINE BIOPHARMA, INC. | Corporate Officer/Principal | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 3 |
|---|---|
Hautes Etudes Commerciales
Hautes Etudes Commerciales Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sunshine Biopharma, Inc.
Sunshine Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes drugs for the treatment of cancer | Health Technology |
Nora Pharma, Inc.
Nora Pharma, Inc. Medical DistributorsDistribution Services Sells generic drugs | Distribution Services |
Kies jouw editie
Alle financiële informatie op nationaal niveau